首页|免疫检查点抑制剂治疗晚期泌尿系统肿瘤致孤立性促肾上腺皮质激素缺乏症相关因素分析

免疫检查点抑制剂治疗晚期泌尿系统肿瘤致孤立性促肾上腺皮质激素缺乏症相关因素分析

扫码查看
目的 探讨免疫检查点抑制剂(ICIs)治疗晚期泌尿系统肿瘤致孤立性促肾上腺皮质激素缺乏症(IAD)的相关因素.方法 对427例患者的临床数据进行回顾性分析,根据纳排标准,剔除不符合要求的病例,将受试者分为ICIs-IAD组(14例)和对照组(垂体功能正常,178例),评估ICIs-IAD的发生率.采用多因素logistic回归分析ICIs-IAD发生的相关因素.结果 ICIs-IAD的发生率为3.28%(14/427).与对照组相比,ICIs-IAD组患者年龄更小,中性粒细胞水平更高(P均<0.05).在校正了其他混杂因素后,多因素logistic回归分析显示低龄(OR=0.912,95%CI:0.845-0.976,P=0.012)和高中性粒细胞水平(OR=1.438,95%CI:1.045-1.977,P=0.020)是发生ICIs-IAD的危险因素.结论 年龄小、中性粒细胞水平升高可能是ICIs-IAD发生的相关因素.
Relative factors analysis of isolated adrenocorticotropin deficiency caused by immune checkpoint inhibitors for advanced urinary system tumors
Objective To investigate the risk factors for isolated adrenocorticotropic hormone defi-ciency induced(IAD)by immune checkpoint inhibitors(ICIs)in patients with advanced urinary system tumors.Methods Clinical data of 427 patients were retrospectively analyzed.According to the inclusion and exclusion criteria,cases that did not meet the requirements were excluded,and the subjects were divid-ed into ICIs-IAD group(14 cases)and control group(normal pituitary function,178 cases).The inci-dence of ICIs-IAD was evaluated.Multivariate logistic regression was used to analyze the relative factors of ICIs-IAD.Results The incidence of ICIs-IAD was 3.28%(14/427).Compared with the control group,patients in the ICIs-IAD group were younger and had higher neutrophil counts(both P<0.05).After adjus-ting for other confounding factors,multiple logistic regression analysis showed that younger age(OR=0.912,95%CI:0.845-0.976,P=0.012)and higher neutrophil count(OR=1.438,95%CI:1.045-1.977,P=0.020)were risk factors for ICIs-IAD.Conclusion Younger age and higher neutrophil count may be associated with the development of ICIs-IAD.

Immune checkpoint inhibitorsAdvanced urinary system tumorsIsolated adrenocorti-cotropic hormone deficiency

赵妍、郭佳欣、赵晶晶、谭艳、蔡启亮

展开 >

天津医科大学第二医院内分泌科,天津 300211

天津市胸科医院内分泌科,天津 300222

天津医科大学第二医院肾内科,天津 300211

天津医科大学第二医院泌尿外科,天津 300211

展开 >

免疫检查点抑制剂 晚期泌尿系统肿瘤 孤立性促肾上腺皮质激素缺乏症

2024

国际内分泌代谢杂志
中华医学会,天津医科大学

国际内分泌代谢杂志

CSTPCD
影响因子:0.842
ISSN:1673-4157
年,卷(期):2024.44(6)